Fluorine MR Imaging of Inflammation in Atherosclerotic Plaque in Vivo.

PURPOSE To preliminarily test the hypothesis that fluorine 19 ((19)F) magnetic resonance (MR) imaging enables the noninvasive in vivo identification of plaque inflammation in a mouse model of atherosclerosis, with histologic findings as the reference standard. MATERIALS AND METHODS The animal studies were approved by the local animal ethics committee. Perfluorocarbon (PFC) emulsions were injected intravenously in a mouse model of atherosclerosis (n = 13), after which (19)F and anatomic MR imaging were performed at the level of the thoracic aorta and its branches at 9.4 T. Four of these animals were imaged repeatedly (at 2-14 days) to determine the optimal detection time. Repeated-measures analysis of variance with a Tukey test was applied to determine if there was a significant change in (19)F signal-to-noise ratio (SNR) of the plaques and liver between the time points. Six animals were injected with a PFC emulsion that also contained a fluorophore. As a control against false-positive results, wild-type mice (n = 3) were injected with a PFC emulsion, and atherosclerotic mice were injected with a saline solution (n = 2). The animals were sacrificed after the last MR imaging examination, after which high-spatial-resolution ex vivo MR imaging and bright-field and immunofluorescent histologic examination were performed. RESULTS (19)F MR signal was detected in vivo in plaques in the aortic arch and its branches. The SNR was found to significantly increase up to day 6 (P < .001), and the SNR of all mice at this time point was 13.4 ± 3.3. The presence of PFC and plaque in the excised vessels was then confirmed both through ex vivo (19)F MR imaging and histologic examination, while no signal was detected in the control animals. Immunofluorescent histologic findings confirmed the presence of PFC in plaque macrophages. CONCLUSION (19)F MR imaging allows the noninvasive in vivo detection of inflammation in atherosclerotic plaques in a mouse model of atherosclerosis and opens up new avenues for both the early detection of vulnerable atherosclerosis and the elucidation of inflammation mechanisms in atherosclerosis.

[1]  Giuseppe Baselli,et al.  A superfluorinated molecular probe for highly sensitive in vivo(19)F-MRI. , 2014, Journal of the American Chemical Society.

[2]  J. Bulte,et al.  (19)F spin-lattice relaxation of perfluoropolyethers: Dependence on temperature and magnetic field strength (7.0-14.1T). , 2014, Journal of magnetic resonance.

[3]  Rolf Schubert,et al.  Probing different perfluorocarbons for in vivo inflammation imaging by 19F MRI: image reconstruction, biological half‐lives and sensitivity , 2014, NMR in biomedicine.

[4]  Hao Hong,et al.  Positron Emission Tomography Imaging of Atherosclerosis , 2013, Theranostics.

[5]  Eric T Ahrens,et al.  Accelerated fluorine‐19 MRI cell tracking using compressed sensing , 2013, Magnetic resonance in medicine.

[6]  U. Eriksson,et al.  Selective In Vivo Visualization of Immune-Cell Infiltration in a Mouse Model of Autoimmune Myocarditis by Fluorine-19 Cardiac Magnetic Resonance , 2013, Circulation. Cardiovascular imaging.

[7]  R. Schreiber,et al.  Programmable nanoparticle functionalization for in vivo targeting , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  Tom MacGillivray,et al.  Ultrasmall Superparamagnetic Particles of Iron Oxide in Patients With Acute Myocardial Infarction: Early Clinical Experience , 2012, Circulation. Cardiovascular imaging.

[9]  C. Müller,et al.  Selective Activation of Adenosine A2A Receptors on Immune Cells by a CD73-Dependent Prodrug Suppresses Joint Inflammation in Experimental Rheumatoid Arthritis , 2012, Science Translational Medicine.

[10]  M. Stuber,et al.  Fluorine-19 Magnetic Resonance Angiography of the Mouse , 2012, PloS one.

[11]  Sebastian Temme,et al.  19F magnetic resonance imaging of endogenous macrophages in inflammation. , 2012, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[12]  K. Nicolay,et al.  Molecular MRI of Inflammation in Atherosclerosis , 2011, Current Cardiovascular Imaging Reports.

[13]  Qing Ye,et al.  19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells , 2011, Magnetic resonance in medicine.

[14]  Matthias Nahrendorf,et al.  Molecular Imaging of Coronary Atherosclerosis and Myocardial Infarction: Considerations for the Bench and Perspectives for the Clinic , 2011, Circulation research.

[15]  J. Tschopp,et al.  Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome , 2011, Cell Death and Disease.

[16]  J. Bulte,et al.  Fluorine (19F) MRS and MRI in biomedicine , 2011, NMR in biomedicine.

[17]  Akiko Maehara,et al.  A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.

[18]  V. Fuster,et al.  Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? , 2010, Journal of the American College of Cardiology.

[19]  D. Laidlaw,et al.  In vivo cytometry of antigen‐specific t cells using 19F MRI , 2009, Magnetic resonance in medicine.

[20]  Martin J Graves,et al.  The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. , 2009, Journal of the American College of Cardiology.

[21]  D. Kraitchman,et al.  Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging. , 2008, Journal of the American College of Cardiology.

[22]  J. Schwitter.  Extending the frontiers of cardiac magnetic resonance. , 2008, Circulation.

[23]  Rolf Schubert,et al.  In Vivo Monitoring of Inflammation After Cardiac and Cerebral Ischemia by Fluorine Magnetic Resonance Imaging , 2008, Circulation.

[24]  Z. Fayad,et al.  Non‐invasive MRI of mouse models of atherosclerosis , 2007, NMR in biomedicine.

[25]  Zahi A Fayad,et al.  Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI , 2007, Proceedings of the National Academy of Sciences.

[26]  P. Libby,et al.  Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease , 2006, Proceedings of the National Academy of Sciences.

[27]  J. Riess.  Perfluorocarbon-based Oxygen Delivery , 2006, Artificial cells, blood substitutes, and immobilization biotechnology.

[28]  Eric T Ahrens,et al.  In vivo imaging platform for tracking immunotherapeutic cells , 2005, Nature Biotechnology.

[29]  E. Eger,et al.  Illustrations of Inhaled Anesthetic Uptake, Including Intertissue Diffusion to and from Fat , 2005, Anesthesia and analgesia.

[30]  Patrick J. Gaffney,et al.  Quantitative “magnetic resonance immunohistochemistry” with ligand‐targeted 19F nanoparticles , 2004 .

[31]  Samuel A Wickline,et al.  Quantitative "magnetic resonance immunohistochemistry" with ligand-targeted (19)F nanoparticles. , 2004, Magnetic resonance in medicine.

[32]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[33]  J. Debatin,et al.  Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits , 2001, Circulation.

[34]  P. Keipert,et al.  Randomized Safety Studies of Intravenous Perflubron Emulsion. II. Effects on Immune Function in Healthy Volunteers , 2000 .

[35]  P. Keipert,et al.  Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers. , 2000, Anesthesia and analgesia.

[36]  R. Ross,et al.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[37]  T. Prolla,et al.  13 C NMR visibility of rabbit muscle glycogen in vivo , 1991, Magnetic resonance in medicine.